학술논문
Targeted therapy with the mutant IDH2 inhibitor enasidenib for high-risk IDH2-mutant myelodysplastic syndrome
Document Type
Article
Author
DiNardo, Courtney D.; Venugopal, Sangeetha; Lachowiez, Curtis; Takahashi, Koichi; Loghavi, Sanam; Montalban-Bravo, Guillermo; Wang, Xuemei; Carraway, Hetty; Sekeres, Mikkael; Sukkur, Ameenah; Hammond, Danielle; Chien, Kelly; Maiti, Abhishek; Masarova, Lucia; Sasaki, Koji; Alvarado, Yesid; Kadia, Tapan; Short, Nicholas J.; Daver, Naval; Borthakur, Gautam; Ravandi, Farhad; Kantarjian, Hagop M.; Patel, Bhumika; Dezern, Amy; Roboz, Gail; Garcia-Manero, Guillermo
Source
In Blood Advances 13 June 2023 7(11):2378-2387
Subject
Language
ISSN
2473-9529